Healthcare - Biotechnology - NASDAQ - US
$ 1.17
-7.14 %
$ 6.9 M
Market Cap
-0.38
P/E
INCOME STATEMENT
4.91 M
REVENUE
-13.3 M
OPERATING INCOME
-13.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Plus Therapeutics, Inc.
| Revenue | 4.91 M |
| Cost Of Revenue | 9.69 M |
| Gross Profit | -4.78 M |
| Operating Expenses | 8.54 M |
| Operating Income | -13.3 M |
| Other Expenses | -5 K |
| Net Income | -13.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||
| Revenue | 4.9 | 0.2 | 0 | 0.3 | 7.0 | 3.0 | 6.4 | 11.4 | 11.7 | 7.6 | 12.2 | 14.5 | 10.0 | 10.6 | 8.9 | 4.5 | 6.0 | 7.9 | 5.6 | 6.8 | 14.1 | 9.2 | 5.6 | 6.3 | 1.5 | 0 |
| GROSS PROFIT | ||||||||||||||||||||||||||
| Cost Of Revenue | 9.7 | 0.7 | 66 K | 2.7 | 5.4 | 1.1 | 1.3 | 2.7 | 3.2 | 2.9 | 3.4 | 4.0 | 3.8 | 3.9 | 3.4 | 1.9 | 0.4 | 1.6 | 3.2 | 3.4 | 4.2 | 3.2 | 4.2 | 2.4 | 0.5 | 0 |
| Gross Profit | (4.8) | (0.5) | 66 K | (2.4) | 1.6 | 1.8 | 5.1 | 8.7 | 8.5 | 4.7 | 8.8 | 10.5 | 6.2 | 6.7 | 5.5 | 2.7 | 5.6 | 6.3 | 2.5 | 3.4 | 9.8 | 6.0 | 1.5 | 3.9 | 1.0 | 0 |
| OPERATING INCOME | ||||||||||||||||||||||||||
| Operating Expenses | 8.5 | 19.9 | 12.4 | 9.9 | 10.7 | 11.7 | 25.8 | 28.4 | 31.4 | 37.5 | 42.1 | 38.8 | 39.2 | 32.0 | 33.8 | 32.4 | 31.7 | 25.7 | 30.5 | 19.4 | 19.1 | 17.5 | 14.7 | 13.5 | 5.5 | 2.1 |
| Selling, General and Administrative Expenses | 8.5 | 10.2 | 6.9 | 6.4 | 5.3 | 6.2 | 11.2 | 12.2 | 12.4 | 22.4 | 25.1 | 25.2 | 28.3 | 23.6 | 17.0 | 16.3 | 16.9 | 14.6 | 15.6 | 8.3 | 9.0 | 7.9 | 8.1 | 5.2 | 3.7 | 0.8 |
| Research and Development Expenses | 9.7 | 9.7 | 5.6 | 3.5 | 5.4 | 5.5 | 13.4 | 16.2 | 19.0 | 15.1 | 17.1 | 13.6 | 10.9 | 9.7 | 12.2 | 15.0 | 20.0 | 22.0 | 15.6 | 11.0 | 9.1 | 7.9 | 5.5 | 2.6 | 1.2 | 1.2 |
| Operating Income | (13.3) | (19.7) | (12.5) | (9.6) | (3.7) | (8.8) | (20.7) | (19.7) | (15.3) | (32.4) | (30.7) | (28.4) | (29.4) | (25.3) | (21.5) | (29.8) | (31.4) | (25.9) | (28.0) | (16.1) | (9.7) | (11.5) | (13.2) | (9.6) | (4.5) | (2.1) |
| PRE-TAX INCOME | ||||||||||||||||||||||||||
| Interest Income Expense | 0.4 | 0.7 | 0.9 | 1.1 | 1.9 | 1.9 | 2.0 | 2.6 | 3.4 | 4.4 | 3.4 | 3.4 | 2.8 | 2.1 | 1.4 | 0.4 | 0.2 | 0.2 | 0.1 | 0.2 | 0 | 0.3 | 0.2 | 0.4 | 0 | 43 K |
| Total Other Income | 5 K | (0.6) | (0.9) | 1.3 | 0.4 | (0.1) | (2.0) | (2.3) | (3.5) | (4.9) | 4.5 | (4.0) | (3.0) | (2.2) | (1.7) | (0.3) | 2.7 | 0.4 | 1.5 | 16.1 | 9.7 | 11.5 | 11.4 | 0 | 4.5 | 0 |
| Pre-Tax Income | (13.3) | (20.3) | (13.4) | (8.2) | (3.3) | (8.9) | (22.7) | (22.0) | (18.7) | (37.4) | (26.2) | (32.3) | (32 451.0) | (27 494.0) | (23 216.0) | (30 036.0) | (28 672.0) | (25 447.0) | (26 538.0) | (2 090.0) | (9 283.0) | (13 003.0) | (11 207.0) | 0 | 0 | 0 |
| NET INCOME | ||||||||||||||||||||||||||
| Tax Provision | 0 | 0.6 | 0.9 | 1.1 | 9.5 | 2.0 | 2.1 | 2.8 | 3.5 | 3.8 | 7.8 | 2.9 | (0.8) | 2.0 | (5.1) | 0.2 | 2.6 | 6.0 | (5.6) | (13.9) | 73 K | 1.5 | (2.0) | (1.0) | 4.6 | 2.1 |
| Net Income | (13.3) | (20.8) | (14.3) | (9.3) | (12.7) | (12.6) | (22.7) | (22.0) | (18.7) | (37.4) | (26.2) | (32.3) | (32.5) | (27.5) | (23.2) | (30.0) | (28.7) | (25.4) | (26.5) | (2.1) | (9.3) | (13.0) | (11.2) | (8.6) | (4.6) | (2.1) |
| EPS | 4.24 | 11.9 | 17.8 | 31.7 | 138 | 1.09 K | 5.25 K | 9.56 K | 15 K | 40.3 K | 39.4 K | 52.5 K | 61.5 K | 56.7 K | 62.2 K | (0.1) | (0.1) | (0.1) | (0.2) | 16.1 K | 71.4 K | 96.3 K | 79.5 K | 7.53 K | 32.6 K | 14.9 K |